Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-054900

Chief Financial Officer sold 10,000 shares at an average $177.49 ($1,774,927)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McAnear Justin J. · Chief Financial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-01 Exercise or conversion : show line 1 in the form +10,000 $5.04 $50,400 49,100 D
2021-09-01 Sale : show line 2 in the form −374 $174.87 $65,401 48,726 D
2021-09-01 Sale : show line 3 in the form −1,139 $175.95 $200,412 47,587 D
2021-09-01 Sale : show line 4 in the form −2,200 $177.00 $389,396 45,387 D
2021-09-01 Sale : show line 5 in the form −4,747 $177.87 $844,359 40,640 D
2021-09-01 Sale : show line 6 in the form −1,540 $178.80 $275,358 39,100 D
Open-market sales · 10,000 sh · avg $177.49 · $1,774,927

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-09-01 Exercise or conversion : show line 7 in the form Stock Option (right to buy) −10,000 $5.04 2028-11-02 10,000 390,159 D
Loading xslF345X03/doc4.xml…